Aislamiento de exosomas a partir de biopsia líquida y su potencial aplicación en la clínica
DOI:
https://doi.org/10.35509/01239015.733Palabras clave:
neoplasias, biopsia líquida, exosomas, biomarcadores de tumor, protocolos antineoplásicosResumen
Los exosomas son microvesículas extracelulares secretadas por las células que han cobrado gran importancia por su potencial aplicación en la clínica para la identificación de nuevos biomarcadores de diagnóstico, pronóstico y seguimiento de enfermedades como el cáncer, o para determinar su potencial aplicación terapéutica. Dado que estas vesículas se encuentran de forma natural en fluidos corporales tales como sangre, orina o saliva, es posible aislarlas a partir de una biopsia líquida para analizar su contenido, dilucidar su interacción con diferentes poblaciones celulares (crosstalk) y determinar su efecto durante el desarrollo de una patología particular. En esta revisión abordamos los últimos hallazgos relacionados con el diseño y la aplicación de terapias que emplean vesículas extracelulares, particularmente exosomas, para el tratamiento del cáncer o como biomarcadores de diagnóstico, pronóstico o seguimiento de la enfermedad.
Biografía del autor/a
Paula Morales, Semillero de Investigación en Inmunobiología Tumoral, Universidad Distrital Francisco José de Caldas (SIIT-UD), Bogotá, D. C., Colombia.
1. Semillero de Investigación en Inmunobiología Tumoral, Universidad Distrital Francisco José de Caldas (SIIT-UD), Bogotá, D. C., Colombia.
Nicolás Molina, Semillero de Investigación en Inmunobiología Tumoral, Universidad Distrital Francisco José de Caldas (SIIT-UD), Bogotá, D. C., Colombia.
1. Semillero de Investigación en Inmunobiología Tumoral, Universidad Distrital Francisco José de Caldas (SIIT-UD), Bogotá, D. C., Colombia.
Josefa Rodríguez , Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología, Bogotá, D. C., Colombia.
2. Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología, Bogotá, D. C., Colombia.
Referencias bibliográficas
Quek C, Hill A. The role of extracellular vesicles in neurodegenerative diseases. Biochem Biophys Res Commun. 2017;483(4):1178-86. https://doi.org/10.1016/j.bbrc.2016.09.090
Cui S, Cheng Z, Qin W, Jiang L. Exosomes as a liquid biopsy for lung cancer. Lung Cancer. 2018;116:46-54. https://doi.org/10.1016/j.lungcan.2017.12.012
Ilié M, Hofman P. Pros: can tissue biopsy be replaced by liquid biopsy? Transl Lung Cancer Res. 2016;5(4):420-3. https://doi.org/10.21037/tlcr.2016.08.06
Fontanilles M, Duran-Peña A, Idbaih A. Liquid Biopsy in Primary Brain Tumors: Looking for Stardust! Curr Neurol Neurosci Rep. 2018;18(3):13. https://doi.org/10.1007/s11910-018-0820-z
Cheng J, Nonaka T, Wong D. Salivary exosomes as nanocarriers for cancer biomarker delivery. Materials. 2019;12(4):654. https://doi.org/10.3390/ma12040654
Santoni G, Morelli MB, Amantini C, Battelli N. Urinary markers in bladder cancer: an update. Front Oncol. 2018;8:362. https://doi.org/10.3389/fonc.2018.00362
Clery E, Pisapia P, Migliatico I, Pepe F, De Luca C, Russo M, et al. Cytology meets next generation sequencing and liquid biopsy: a case of lung adenocarcinoma presenting as metastasis to the phalanx. Diagn Cytopathol. 2020;48(8):759-64. https://doi.org/10.1002/dc.24438
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74. https://doi.org/10.1016/j.cell.2011.02.013
Lu Y-T, Delijani K, Mecum A, Goldkorn A. Current status of liquid biopsies for the detection and management of prostate cancer. Cancer Manag Res . 2019;11:5271-91. https://doi.org/10.2147/CMAR.S170380
Hu Y, Yu X, Xu G, Liu S. Metastasis: an early event in cancer progression. J Cancer Res Clin Oncol. 2017;143(5):745-57. https://doi.org/10.1007/s00432-016-2279-0
Joosse S, Pantel K. Tumor-educated platelets as liquid biopsy in cancer patients. Cancer Cell. 2015;28(5):552-4. https://doi.org/10.1016/j.ccell.2015.10.007
Brinkman K, Meyer L, Bickel A, Enderle D, Berking C, Skog J, et al. Extracellular vesicles from plasma have higher tumour RNA fraction than platelets. J Extracell Vesicles. 2020;9(1):1741176. https://doi.org/10.1080/20013078.2020.1741176
Nonaka T, Wong D. Liquid biopsy in head and neck cancer: promises and challenges. J Dent Res. 2018;97(6):701-8. https://doi.org/10.1177/0022034518762071
Lousada-Fernandez F, Rapado-Gonzalez O, Lopez-Cedrun J-L, Lopez-Lopez R, Muinelo-Romay L, Suarez-Cunqueiro M. Liquid biopsy in oral cancer. Int J Mol Sci. 2018;19(6):1704. https://doi.org/10.3390/ijms19061704
Iwai K, Minamisawa T, Suga K, Yajima Y, Shiba K. Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations. J Extracell Vesicles. 2016;5(1):30829. https://doi.org/10.3402/jev.v5.30829
Ogawa Y, Tsujimoto M, Yanoshita R. Next-generation sequencing of protein-coding and long non-protein-coding RNAs in two types of exosomes derived from human whole saliva. Biol Pharm Bull. 2016;39(9):1496-507. https://doi.org/10.1248/bpb.b16-00297
Xiao H, Zhang Y, Kim Y, Kim S, Kim J, Kim K, et al. Differential proteomic analysis of human saliva using tandem mass tags quantification for gastric cancer detection. Sci Rep. 2016;6(1):22165. https://doi.org/10.1038/srep22165
Jain S, Lin S, Song W, Su Y-H. Urine-based liquid biopsy for nonurological cancers. Genet Test Mol Biomarkers. 2019;23(4):277-83. https://doi.org/10.1089/gtmb.2018.0189
Srivastava A, Moxley K, Ruskin R, Dhanasekaran DN, Zhao YD, Ramesh R. A Non-invasive liquid biopsy screening of urine-derived exosomes for miRNAs as biomarkers in endometrial cancer patients. AAPS J. 2018;20(5):82. https://doi.org/10.1208/s12248-018-0220-y
Elsharkawi F, Elsabah M, Shabayek M, Khaled H. Urine and serum exosomes as novel biomarkers in detection of bladder cancer. Asian Pacific J Cancer Prev. 2019;20(7):2219-24. https://dx.doi.org/10.31557/APJCP.2019.20.7.2219
Ponti G, Maccaferri M, Manfredini M, Micali S, Torricelli F, Milandri R, et al. Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis. Clin Chim Acta. 2019;497:76-80. https://doi.org/10.1016/j.cca.2019.07.011
Bertero L, Siravegna G, Rudà R, Soffietti R, Bardelli A, Cassoni P. Review: peering through a keyhole: liquid biopsy in primary and metastatic central nervous system tumours. Neuropathol Appl Neurobiol. 2019;45(7):655-70. https://doi.org/10.1111/nan.12553
Huang T, Piunti A, Lulla R, Qi J, Horbinski C, Tomita T, et al. Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol Commun. 2017;5(1):28. https://doi.org/10.1186/s40478-017-0436-6
Saenz-Antoñanzas A, Auzmendi-Iriarte J, Carrasco-Garcia E, Moreno-Cugnon L, Ruiz I, Villanua J, et al. Liquid biopsy in glioblastoma: opportunities, applications and challenges. Cancers. 2019;11(7):950. https://doi.org/10.3390/cancers11070950
Shankar G, Balaj L, Stott S, Nahed B, Carter B. Liquid biopsy for brain tumors. Expert Rev Mol Diagn. 2017;17(10):943-7. https://doi.org/10.1080/14737159.2017.1374854
Srivastava A, Amreddy N, Razaq M, Towner R, Zhao Y, Ahmed R, et al. Exosomes as Theranostics for Lung Cancer. En: Broome A-M, editora, Advances in Cancer Research. Sur Carolina, Estados Unidos; 2018. p. 1-33. https://doi.org/10.1016/bs.acr.2018.04.001
Kalluri R, LeBleu V. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. https://doi.org/10.1126/science.aau6977
Kalluri R. The biology and function of exosomes in cancer. J Clin Invest. 2016;126(4):1208-15. https://doi.org/10.1172/JCI81135
Fu M, Gu J, Jiang P, Qian H, Xu W, Zhang X. Exosomes in gastric cancer: roles, mechanisms, and applications. Mol Cancer. 2019;18(1):41. https://doi.org/10.1186/s12943-019-1001-7
Reclusa P, Sirera R, Araujo A, Giallombardo M, Valentino A, Sorber L, et al. Exosomes genetic cargo in lung cancer: a truly Pandora’s box. Transl Lung Cancer Res. 2016;5(5):483-91. http://dx.doi.org/10.21037/tlcr.2016.10.06
Zhu L, Gangadaran P, Kalimuthu S, Oh J, Baek S, Jeong S, et al. Novel alternatives to extracellular vesicle-based immunotherapy - exosome mimetics derived from natural killer cells. Artif Cells Nanomed Biotechnol. 2018;46(supl. 3):S166-79. https://doi.org/10.1080/21691401.2018.1489824
Tauro B, Greening D, Mathias R, Mathivanan S, Ji H, Simpson R. Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics. 2013;12(3):587-98. https://doi.org/10.1074/mcp.M112.021303
Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med. 2013;91(4):431-7. https://doi.org/10.1007/s00109-013-1020-6
Whiteside T. Tumor-derived exosomes and their role in cancer progression. En: Makowski G, editora. Advances in Clinical Chemistry. Connecticut, Estados Unidos; 2016. p. 103-41. https://doi.org/10.1016/bs.acc.2015.12.005
Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015;4(1):30087. https://doi.org/10.3402/jev.v4.30087
Urbanelli L, Buratta S, Sagini K, Ferrara G, Lanni M, Emiliani C. Exosome-based strategies for diagnosis and therapy. Recent Pat CNS Drug Discov. 2015;10(1):10-27. http://dx.doi.org/10.2174/1574889810666150702124059
Livshits M, Khomyakova E, Evtushenko E, Lazarev V, Kulemin N, Semina S, et al. Erratum: Corrigendum: Isolation of exosomes by differential centrifugation: theoretical analysis of a commonly used protocol. Sci Rep. 2016;6(1):21447. https://doi.org/10.1038/srep21447
Li P, Kaslan M, Lee S, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789-804. https://doi.org/10.7150/thno.18133
Yu L-L, Zhu J, Liu J-X, Jiang F, Ni W-K, Qu L-S, et al. A comparison of traditional and novel methods for the separation of exosomes from human samples. Biomed Res Int. 2018;3634563. https://doi.org/10.1155/2018/3634563
Yamauchi M, Shimizu K, Rahman M, Ishikawa H, Takase H, Ugawa S, et al. Efficient method for isolation of exosomes from raw bovine milk. Drug Dev Ind Pharm. 2019;45(3):359-64. https://doi.org/10.1080/03639045.2018.1539743
Cheruvanky A, Zhou H, Pisitkun T, Kopp J, Knepper M, Yuen P, et al. Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am J Physiol Renal Physiol. 2007;292(5):F1657-61. https://doi.org/10.1152/ajprenal.00434.2006
Zeringer E, Barta T, Li M, Vlassov A. Strategies for isolation of exosomes. Cold Spring Harb Protoc. 2015;2015(4):319-23. https://doi.org/10.1101/pdb.top074476
Sumrin A, Moazzam S, Khan A, Ramzan I, Batool Z, Kaleem S, et al. Exosomes as biomarker of cancer. Braz Arch Biol Technol. 2018;61. https://doi.org/10.1590/1678-4324-2018160730
Kang Y-T, Purcell E, Palacios-Rolston C, Lo T-W, Ramnath N, Jolly S, et al. Isolation and profiling of circulating tumor-associated exosomes using extracellular vesicular lipid-protein binding affinity based microfluidic device. Small. 2019;15(47):e1903600. https://doi.org/10.1002/smll.201903600
Kanwar S, Dunlay C, Simeone D, Nagrath S. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip. 2014;14(11):1891-900. https://doi.org/10.1039/C4LC00136B
Biswas S, Mandal G, Chowdhury S, Purohit S, Payne K, Anadon C, et al. Exosomes produced by mesenchymal stem cells drive differentiation of myeloid cells into immunosuppressive M2-polarized macrophages in breast cancer. J Immunol. 2019;203(12):3447-60. https://doi.org/10.4049/jimmunol.1900692
Rashed M, Bayraktar E, K. Helal G, Abd-Ellah M, Amero P, Chavez-Reyes A, et al. Exosomes: from garbage bins to promising therapeutic targets. Int J Mol Sci. 2017;18(3):538. https://doi.org/10.3390/ijms18030538
Tai Y-L, Chen K-C, Hsieh J-T, Shen T-L. Exosomes in cancer development and clinical applications. Cancer Sci. 2018;109(8):2364-74. https://doi.org/10.1111/cas.13697
Mughees M, Kumar K, Wajid S. Exosome vesicle as a nano-therapeutic carrier for breast cancer. J Drug Target. 2021;29(2):121-30. https://doi.org/10.1080/1061186X.2020.1808001
Beckman J, Minor R, White C, Repine J, Rosen G, Freeman B. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J Biol Chem. 1988;263(14):6884-92. https://doi.org/10.1016/S0021-9258(18)68727-7
Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9(8):581-93 https://doi.org/10.1038/nri2567
Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood M. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341-5. https://doi.org/10.1038/nbt.1807
Wiklander O, Nordin J, O’Loughlin A, Gustafsson Y, Corso G, Mäger I, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4(1):26316. https://doi.org/10.3402/jev.v4.26316
Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B. 2016;6(4):287-96. https://doi.org/10.1016/j.apsb.2016.02.001
Batrakova E, Kim M. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release. 2015;219:396-405. https://doi.org/10.1016/j.jconrel.2015.07.030
Lu Z, Zuo B, Jing R, Gao X, Rao Q, Liu Z, et al. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models. J Hepatol. 2017;67(4):739-48. https://doi.org/10.1016/j.jhep.2017.05.019
Cho J, Lee Y-S, Kim S-H, Ko J-K, Kim C-W. MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models. Cancer Lett. 2009;275(2):256-65. https://doi.org/10.1016/j.canlet.2008.10.021
Cheng L, Wang Y, Huang L. Exosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node. Mol Ther. 2017;25(7):1665-75. https://doi.org/10.1016/j.ymthe.2017.02.007
Sarvizadeh M, Ghasemi F, Tavakoli F, Sadat S, Razi E, Sharifi H, et al. Vaccines for colorectal cancer: an update. J Cell Biochem. 2019;120(6):8815-28. https://doi.org/10.1002/jcb.28179
Cómo citar
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2021 Revista Colombiana de Cancerología

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Todos los derechos reservados.
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
Datos de los fondos
-
Instituto Nacional de Cancerología
Números de la subvención Proyecto “Utilidad clínica de la molécula HLA-G soluble en el diagnóstico y pronostico del Cáncer Gástrico” con código xRPM N° C19010300-408

